Back to top
more

Medpace (MEDP)

(Delayed Data from NSDQ)

$393.91 USD

393.91
128,196

-0.19 (-0.05%)

Updated Jun 14, 2024 03:59 PM ET

After-Market: $393.72 -0.19 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 249)

Industry: Medical Services

Better trading starts here.

Zacks News

Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised

Strength in the Life Science and Clinical Diagnostics segments drove Bio-Rad's (BIO) revenues in the third quarter.

Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now?

Smart Beta ETF report for RFG

Medpace (MEDP) Tops Q3 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 20.56% and 1.20%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Medpace (MEDP) Q3 Earnings Expected to Decline

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medpace (MEDP) Moves 3.3% Higher: Will This Strength Last?

Medpace (MEDP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Medpace (MEDP) Moves to Buy: Rationale Behind the Upgrade

Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Medpace (MEDP) Q2 Earnings and Revenues Beat Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 8.16% and 2.62%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medpace (MEDP) Q1 Earnings Surpass Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 15.84% and -1.90%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Earnings Expected to Grow: Should You Buy?

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Strength Seen in Medpace (MEDP): Can Its 3.5% Jump Turn into More Strength?

Medpace (MEDP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teladoc (TDOC) and Dexcom Offer New Solutions for Diabetes

Teladoc (TDOC) and Dexcom jointly provide solutions for patients with Type 2 diabetes, a common lifestyle-induced malady.

Medpace (MEDP) Tops Q3 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 4.63% and 2.74%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Top Ranked Momentum Stocks to Buy for August 28th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 28th.

Top Ranked Momentum Stocks to Buy for August 26th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 26th.

Top Ranked Momentum Stocks to Buy for August 24th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 24th.

Medpace (MEDP) is a Great Momentum Stock: Should You Buy?

Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Top Ranked Momentum Stocks to Buy for August 20th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 20th.

Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners

Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners

The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings

The Zacks Analyst Blog Highlights: Houghton Mifflin Harcourt Company, CoreLogic, FTI Consulting, Artisan Partners Asset Management and Medpace Holdings

Urmimala Biswas headshot

Near-Term Outlook Tepid for Medical Services Industry

This sector witnesses growing demand for telemedicine-focused online medical services amid the pandemic.

Tirthankar Chakraborty headshot

Service Side of US Economy is Up and Running: 5 Top Picks

The service sector index read 58.1% in July, a 17-month high. Lest we forget, a reading above 48.5% indicates expansion of the broader economy.

Bet on These 5 Low Leverage Stocks This Earnings Season

Debt is something that gives you the chills since it brings with it the burden of repayment with additional interest in the future. So investors should choose stocks prudently